<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":2186,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
SEC v. Morgan Keegan & Co., 678 F.3d 1233 (11th Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/e2ce47aedc09393b1f207adc43ffc06c'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/e2ce47aedc09393b1f207adc43ffc06c'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1HKTH2003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HKTH2003">Previous Result: <span>Guevara-Calderon v. Holder, 472 Fed. App...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1HL678003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1HL678003">Next Result: <span>Aguilar v. LR Coin Laudromat, Inc., Civi...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation positive" title="Positive"></div>
<div class='title left' title='SEC v. Morgan Keegan &amp; Co., 678 F.3d 1233 (11th Cir. 2012), Court Opinion'>
SEC v. Morgan Keegan &amp; Co., 678 F.3d 1233 (11th Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>SEC v. Morgan Keegan & Co., 678 F.3d 1233 (11th Cir. 2012), Court Opinion</div>
<div class='docId'>X1HKNVU003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>SEC v. Morgan Keegan & Co.</div>
<div class='displayCitation'>2012 BL 107481</div>
<div class='displayCitation'>678 F.3d 1233</div>
<div class='displayCitation'>wkf11case:26030079</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1HKNVU003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="SEC v. Morgan Keegan &amp; Co., 678 F.3d 1233 (11th Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="SEC v. Morgan Keegan &amp; Co." />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1HKNVU003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1HKNVU003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1HKNVU003" /><input id="title" name="title" type="hidden" value="SEC v. Morgan Keegan &amp; Co., 678 F.3d 1233 (11th Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="POSITIVE" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="e2ce47aedc09393b1f207adc43ffc06c" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1HKNVU003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2Fe%32ce%34%37aedc%30%39%33%39%33b%31f%32%30%37adc%34%33ffc%30%36c%2Fdocument%2FX%31HKNVU%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/bcite/X1HKNVU003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/bcite/X1HKNVU003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/bcite/X1HKNVU003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/related_content/X1HKNVU003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1705907257347";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">678 F.3d 1233</div>
<div class="cite" data-cite-type="DocketNumber">11-13992</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 107481</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Eleventh Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
SECURITIES AND EXCHANGE COMMISSION, Plaintiff-Appellant, v. MORGAN
KEEGAN &amp; COMPANY, INC., Defendant-Appellee.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 11-13992.
</center></p>
<p><center>
May 2, 2012.
</center></p>
<span CLASS="page_no" data-cite="678 f 3d 1234" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1234" data-primary-citation="678 F.3d 1233">[*1234]</span> <div id="contentOpinion" printdualcolumn="true"><div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
[EDITORS' NOTE:  THIS PAGE CONTAINS HEADNOTES. HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
<span CLASS="page_no" data-cite="678 f 3d 1235" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1235" data-primary-citation="678 F.3d 1233">[*1235]</span> 
</p></div></div>
<div id="para2" printdualcolumn="true"><p>
  Tracey Hardin, U.S. Securities &amp; Exchange Commission,
Office of the General Counsel, Washington, DC, Robert K.
Gordon, William P. Hicks, Madison Graham Loomis, James
Alexander Rue, U.S. Securities &amp; Exchange Commission,
Atlanta, GA, for Plaintiff-Appellant.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Amelia Toy Rudolph, Peter J. Anderson, Aaron S. Furniss, Yvonne
M. Williams, Sutherland Asbill &amp; Brennan, LLP, Atlanta, GA,
Michele A. Coffey, John Shin, Morgan Lewis &amp; Bockius, LLP,
New York City, for Defendant-Appellee.
<span CLASS="page_no" data-cite="678 f 3d 1236" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1236" data-primary-citation="678 F.3d 1233">[*1236]</span> 
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Appeal from the United States District Court for the
Northern District of Georgia.
</p></div>
<div id="para2" printdualcolumn="true"><p>
  Before BARKETT and HULL, Circuit Judges, and HINKLE,<a HREF="#fn*00" name="fnref_fn*00">[fn*]</a>
District Judge.
</p></div>
<div id="para2" printdualcolumn="true"><p>
<span class="fr"><a HREF="#fnref_fn*00" name="fn*00">[fn*]</a></span> Honorable Robert L. Hinkle, United States District Judge
for the Northern District of Florida, sitting by
designation.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  PER CURIAM:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In this civil enforcement action, the Securities and
Exchange Commission ("SEC") sued Defendant Morgan Keegan
&amp; Co. ("Morgan Keegan") for violating <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">&sect;&sect; 10(b)</a> and <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X7FH2G003?jcsearch=15%20U.S.C.%20%2078o(c)(1)&amp;summary=yes#jcite">15(c)(1)</a> of
the Exchange Act, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)&amp;summary=yes#jcite">&sect; 17(a)</a> of the Securities Act, and
SEC <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>. The SEC alleges that, in the critical time period
of late 2007 and early 2008, Morgan Keegan's brokers (1)
misrepresented that auction rate securities ("ARS") were safe
cash-equivalents with no liquidity risk and (2) despite myriad
auction failures and significant trouble in the ARS market,
continued to recommend ARS as short-term, liquid investments
and failed to disclose the known liquidity risk. The district
court granted summary judgment to Morgan Keegan. After review
and with the benefit of oral argument, we vacate and remand for
further proceedings.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                          <b>I. FACTUAL BACKGROUND</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Defendant Morgan Keegan is an investment firm with more than
1,200 brokers and 300 offices throughout the southeast. The
firm offers financial products and services, such as securities
brokerage, asset management, financial planning, mutual funds,
securities underwriting, sales and trading, and investment
advice. Morgan Keegan participated in the ARS market by
underwriting and selling ARS that were AAA-rated, issued by
municipalities, and tax exempt. Morgan Keegan underwrote
approximately $1.1 billion of ARS. Morgan Keegan also sold ARS
underwritten by other firms. This action centers on Morgan
Keegan's sales of ARS.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>A. Auction Rate Securities</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In the early 1980s, ARS were first offered for sale in the
United States. ARS were generally issued as municipal bonds,
corporate bonds, or preferred stock. By the beginning of 2008,
there were approximately $330 billion of outstanding ARS.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  ARS typically have long-term maturities, or no maturity at all.
Yet, ARS were conceived as highly liquid investments designed
to serve as an equivalent to money-market funds and are
structured for short-term holding periods.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  ARS have a floating interest rate (or dividend) that resets
periodically. The interest rate (or dividend) for an issuance
of ARS is reset through a "Dutch auction" that occurs every 7,
28, or 35 days, depending on the governing <span CLASS="page_no" data-cite="2012 bl 107481 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> documents. In a
Dutch auction, investors purchase and sell the securities
at par value, typically $25,000 per share. In advance of an
auction, a potential investor submits a bid (or "buy order") to
the managing broker-dealer (typically the underwriter of the
issuance), specifying the number of ARS shares the investor
wants to purchase and the minimum interest rate the investor
will accept. Existing holders of ARS can submit "sell orders"
to sell a specified number of shares at a certain interest
rate, or "hold orders" to hold a specified number of shares.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  An auction succeeds, or "clears," if investors submit enough
"buy orders" to cover the "sell orders." In a successful
auction, the "clearing rate" is the lowest interest rate that
will cover all the "buy
<span CLASS="page_no" data-cite="678 f 3d 1237" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1237" data-primary-citation="678 F.3d 1233">[*1237]</span> 
orders." The clearing rate applies to each buy order that
is accepted, regardless of whether the buyer was willing to
accept a lower rate.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  An auction fails if there are insufficient buy orders to
purchase all of the shares offered for sale. If an auction
fails, the ARS interest rate resets to the "maximum rate" until
the next auction, and all of the current holders continue to
hold the securities, with minor exceptions. The maximum rate is
usually either a fixed rate or a floating rate, depending on
the governing documents. Although an auction failure means that
the ARS investment is illiquid, the holder continues to receive
interest payments at the maximum rate, which is intended to
compensate the holder for the loss of liquidity until the next
successful auction. In other words, even if an auction fails,
the issuer must continue to make all interest payments due to
holders of the ARS.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Underwriters of ARS, such as Morgan Keegan, historically
prevented auction failure by placing "supporting" bids to
purchase, for their own accounts, the excess securities offered
for sale. The underwriter then would typically hold these
securities in its own inventory. Morgan Keegan, either as buyer
or seller, submitted orders in auctions for its own account to
help ensure the liquidity of its customers' ARS.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>B. 2008 Collapse of the ARS Market</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Historically, ARS auctions rarely failed, and the ARS market
was a relatively safe and liquid market. Beginning in the
second half of 2007, however, ARS auctions began to fail. In a
November 2007 email, the head of Morgan Keegan's short-term
products desk commented, "We are in a credit crunch &amp; it
will get worse before it gets better . . . Wall Street can't
carry anymore [ARS] paper."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In early February 2008, auctions failed at increasing rates,
restricting the ability of investors to liquidate their ARS and
access their funds. This increased auction failure resulted
from most ARS underwriters, other than Morgan Keegan, ceasing
to place supporting bids. On February 8, 2008, the first
auction co-brokered by Morgan Keegan failed. In an email sent
that day, Frank Phillips, Morgan Keegan's head of retail
trading, stated that Morgan Keegan had suspended all buying of
ARS from dealers other than Morgan Keegan. On February 9, 2008,
Phillips sent an email to Kevin Giddis, the head of Morgan
Keegan's retail <span CLASS="page_no" data-cite="2012 bl 107481 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> fixed income trading desk, expressing concern
about ARS auction failures and brokers' misunderstandings of
ARS:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The [ARS auction] failure[s] have potential to kill
  consumer confidence and could cause a panic to sell
  based on fear of losing liquidity. If this scenario of
  yelling fire in a crow[ded] room plays out, then other
  types of auction rate securities will begin to fail
  and I fear, will show that a lot of brokers have
  misrepresented [the] product to their clients.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Being that I trade the auction rates, I know a lot of
  brokers do not understand the product fully and do not
  know what a failed auction means. If the broker
  doesn't understand what a failed auction is, do you
  think the customer does? Unfortunately, I don't think
  so.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
By February 12, 2008, there were approximately 100 failures in
auctions in which Morgan Keegan played some participating role
(although not as lead manager).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On February 13, 2008, many major ARS underwriters stopped
supporting auctions, and auctions failed on a widespread basis.
On February 15, 2008, Giddis sent Morgan Keegan's brokers an
email titled "AUCTION-RATE UPDATE-PLEASE READ." The email
included an attachment describing the state of the ARS market
<span CLASS="page_no" data-cite="678 f 3d 1238" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1238" data-primary-citation="678 F.3d 1233">[*1238]</span> 
and states, "Share the information with your customer but
please don't send out." Marked for internal use only, the
attachment describes the ARS market issues as
"liquidity-driven" rather than "credit-driven," and includes
background information about what happens when an auction
fails. In a section titled "Advice to Investors and Financial
Advisors," the attachment states that "the credit quality of
the auction rate market remains strong" and that no investor
has lost principal on a deal in which Morgan Keegan was
involved. The attachment further advises brokers to avoid the
"impulse" to sell their customers' ARS:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We stress the importance of ignoring the impulse to
  "test" the process by selling your clients' ARS
  holdings in a wholesale manner simply because you or
  your clients might be worried you will not be able to
  sell them; we maintain our commitment to supporting
  the ARS market to the extent possible, but this is
  only possible with your cooperation. Remember, your
  clients are being well-compensated for holding their
  ARS positions and the liquidity concerns should
  eventually sort themselves out.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Morgan Keegan continued to support auctions by buying ARS for
its own account and thereby provided liquidity for its ARS
customers. As a result, Morgan Keegan's ARS inventory increased
from $18 million to $54 million by February 8, 2008, to $133
million by February 15, 2008, to $179 million by February 21,
2008. On February 22, 2008, Giddis again emailed Morgan
Keegan's brokers and noted that some auctions were still
succeeding and that none of the auctions for which Morgan
Keegan was the lead manager had failed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On February 27, 2008, Morgan Keegan elected to cap its ARS
inventory at $182 to 185 million. After reaching the inventory
cap, Morgan Keegan stopped purchasing ARS for its own account.
On February 28, 2008, the first Morgan Keegan-managed auction
failed. As a result <span CLASS="page_no" data-cite="2012 bl 107481 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> of the 2008 market collapse, Morgan
Keegan's ARS customers could not sell their securities through
the auction process or liquidate their investments.<a HREF="#fn100" name="fnref_fn100">[fn1]</a> In the
end and as of March 20, 2008, Morgan Keegan's customers were
left holding approximately $2.2 billion of ARS, including
approximately $1.1 billion of ARS underwritten by Morgan
Keegan.<a HREF="#fn200" name="fnref_fn200">[fn2]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>C. 2006 SEC Investigation of Morgan Keegan's Intervention</b>
<b>in ARS Auctions</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In 2006 (prior to this 2009 action), the SEC investigated the
ARS underwriting and auction procedures of Morgan Keegan and
other broker-dealers. Ultimately, the SEC issued a May 31, 2006
cease-and-desist order against Morgan Keegan and several other
broker-dealers. <i>See In re Bear, Stearns &amp; Co., et</i>
<i>al.</i>, Securities Act Release No. 8684, Exchange Act Release
No. 53888, <cite>88 SEC Docket 259</cite> (May 31, 2006).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The SEC charged each of the broker-dealers, including Morgan
Keegan, with violating <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)(2)&amp;summary=yes#jcite">&sect; 17(a)(2)</a> of the Securities Act by
engaging in improper ARS auction practices. In settling the
SEC's administrative charges, the broker-dealers consented to
the issuance' of a cease-and-desist order, censure, and payment
of a civil fine.
<span CLASS="page_no" data-cite="678 f 3d 1239" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1239" data-primary-citation="678 F.3d 1233">[*1239]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The May 31, 2006 cease-and-desist order states that the
broker-dealers, or at least some of them, committed the
following "violative practices": (1) completing "open" or
"market" bids, which allowed the broker-dealer to designate
some of the bid's parameters and which advantaged the investors
submitting open or market bids by displacing other investors'
bids; (2) without proper disclosure, intervening in auctions to
prevent failed auctions or to set a market rate; (3)
prioritizing certain customers' bids to increase the likelihood
that those bids would be filled; (4) submitting or revising
bids after auction deadlines; (5) improperly allocating ARS to
investors who bid at the clearing rate instead of allocating
them pro rata, as stated in the disclosure documents; (6) in
over-subscribed auctions, not requiring certain customers to
purchase the pro rata share of ARS for which they had bid, even
though the bids were supposed to be irrevocable; (7) providing
certain customers with returns above the auction clearing rate
based on "an express or tacit understanding reached prior to or
during an auction"; and (8) providing different "price talk" to
certain investors, giving those investors an advantage in
determining what rate to bid. <i></i><cite>Id. at 5-6</cite>. In a
footnote, the SEC specifically noted that it was not
prohibiting broker-dealers from bidding for their own accounts
if proper disclosures were made.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In the cease-and-desist order, each broker-dealer agreed to
provide all of its <i>current</i> ARS customers and the ARS
issuers "with a written description of the [broker-dealer's]
material auction practices and procedures." <i></i><cite>Id. at 8</cite>.
Additionally, each broker-dealer agreed to provide all
<i>first-time</i> ARS purchasers with a written description
of the broker-dealer's "material auction practices and
procedures." <i><cite>Id</cite>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The cease-and-desist order allows a broker-dealer to fulfill
this notice requirement as to first-time ARS purchasers "by
including a written notification <i>with the trade</i>
<i>confirmation</i>, that <span CLASS="page_no" data-cite="2012 bl 107481 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> a written description of the
[broker-dealer's] material auction practices and procedures
<i>is available on a specified web page of the</i>
<i>[broker-dealer's] website accessible" to those first-time</i>
<i>purchasers. <cite>Id</cite>.</i> (emphasis added). This written
notification with the trade confirmation (1) "must be set forth
prominently in such a manner as to call it to the attention of
the reader" and (2) must state that a written description of
the brokerdealer's "material auction practices and procedures"
will be sent to the purchaser upon request. <i><cite>Id</cite>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>D. Trade Confirmations Sent to ARS Purchasers</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Each Morgan Keegan customer who purchased ARS received a trade
confirmation after purchasing ARS. The trade confirmations
primarily provide information about each transaction, including
the security purchased, the price, the trade date, and the
issuance and maturity dates of the security.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Morgan Keegan's trade confirmations state, "For information
regarding the auction procedures refer to the Morgan Keegan
website. Copies available upon request." The home page of
Morgan Keegan's website is listed in the top right corner as
<u>www.morgankeegan.com.</u> Although the trade
confirmations refer to "auction procedures," they do not refer
to "auction practices and procedures." Importantly for this
case, the trade confirmations do not identify a specific web
page on Morgan Keegan's website that contains its ARS auction
practices and procedures.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Morgan Keegan's trade confirmations also do not refer to
liquidity risk. At best, the back side of the trade
confirmations contain a generic statement that investments
<span CLASS="page_no" data-cite="678 f 3d 1240" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1240" data-primary-citation="678 F.3d 1233">[*1240]</span> 
in securities involve "investment risks." Specifically, the
back side of each trade confirmation states, "Securities are
not deposits or obligations of any bank Investments in
securities involve investment risks, including the loss of
principal."<a HREF="#fn300" name="fnref_fn300">[fn3]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The trade confirmations state that (1) "[i]f this or any
transaction is in error or not in accordance with your
understanding or instructions, please inform our Customer
Service Department immediately," and (2) the transaction is
"conclusive and binding if not objected to in writing within
ten business days."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>E. ARS Web Page</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although the trade confirmations do not mention liquidity risk,
an ARS web page posted on Morgan Keegan's website shows that
Morgan Keegan knew how to advise customers about liquidity
risk. The ARS web page first describes ARS as "A Great Place
for Short-Term Money" and states that many investors find ARS
"to be an attractive alternative" to tax-exempt money market
funds, commercial paper, certificates of deposit, and U.S.
Treasury bills. However, the ARS web page then cautions that
"ARS provide (but do not guarantee) liquidity at par through
weekly and 35 day auctions."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  More significantly, this same ARS web page later on
specifically mentions the liquidity risk associated with ARS,
and distinguishes between ARS and money-market funds, as
follows:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  You should be aware that investing in auction rate
  securities involves certain considerations that
  differentiate such securities from money market
  <span CLASS="page_no" data-cite="2012 bl 107481 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> investment instruments.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  &bull; Liquidity Risk &mdash; The ability of an
  investor to dispose of a share of an auction rate
  security may be largely dependent on the success of
  the auction.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  There is no assurance that any particular auction will
  be successful, and neither the issuer nor any broker
  dealer is obligated to take any action to ensure that
  an auction will be successful. In the absence of
  successful auctions, there is no assurance that a
  secondary market for the auction will develop or, if
  such a market does develop, that shares will trade at
  or close to par.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The SEC does not contest that the ARS web page, as a whole,
adequately describes the liquidity risk of ARS. The
SEC complains, however, that Morgan Keegan did not give the ARS
information on this web page directly to its customers and did
not even direct its customers to this web page or make the ARS
web page easily accessible to its customers. The SEC notes that
accessing this ARS web page required four separate navigation
steps from Morgan Keegan's homepage. And, despite the
requirements in the cease-and-desist order, Morgan Keegan's
trade confirmations did not provide customers with the URL for
the ARS web page where they could find the description of
Morgan Keegan's auction practices and procedures.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although it asserts that its ARS web page was easily
accessible, Morgan Keegan has not cited to us any evidence
showing the structure of its website or the navigation
necessary to find its ARS web page. The only evidence in the
record is a five-page printout of an archived version of the
web page itself.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>F. ARS Manual</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In addition to this ARS web page, Morgan Keegan relies on its
24-page manual
<span CLASS="page_no" data-cite="678 f 3d 1241" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1241" data-primary-citation="678 F.3d 1233">[*1241]</span> 
(the "ARS Manual") describing its auction practices and
procedures. After the May 31, 2006 cease-and-desist order,
Morgan Keegan prepared and sent this ARS Manual to all
customers who already held ARS at the time the AES Manual was
prepared.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Like the ARS web page, the ARS Manual shows that Morgan Keegan
was aware of, and knew how to disclose, the liquidity risk of
ARS. For example, the ARS Manual has the same information
quoted above from the shorter ARS web page that discusses the
liquidity risk of ARS. The ARS Manual also warns that
"[h]olders who have submitted sell orders should be aware that,
in the event of an auction failure, they will not be able to
sell all, and may not be able to sell any, securities in the
auction." A section entitled "Risk Factors and Special
Considerations" explains that (1) Morgan Keegan may act as a
buyer or seller in auctions, but is not obligated to do so, and
(2) the fact that an auction clears successfully does not mean
that an ARS investment "involves no significant liquidity or
credit risk." Under a section styled "No Assurances Regarding
Auction Outcomes," Morgan Keegan warns that it "provides no
assurance as to the outcome of any auction. Nor does Morgan
Keegan provide any assurance that any bid will be successful,
in whole or in part, or that any auction will clear at a rate
that a bidder considers acceptable."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Also like the ARS web page, the SEC does not dispute that the
ARS Manual adequately <span CLASS="page_no" data-cite="2012 bl 107481 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> advises about liquidity risk. Rather, the
SEC stresses that Morgan Keegan did not make the ARS Manual's
disclosures readily accessible to new ARS customers in 2008 and
did nothing else to ensure its customers saw or even knew about
the ARS Manual.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  It is undisputed that Morgan Keegan did not require its brokers
to distribute copies of the ARS Manual directly to new
customers before or after they purchased ARS. And even though
the ARS Manual was apparently posted somewhere on Morgan
Keegan's website, Morgan Keegan has not cited evidence showing
specifically where it was on the website or how a customer
would navigate to it.<a HREF="#fn400" name="fnref_fn400">[fn4]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>G. ARS Brochure and New Disclosure Procedure</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  To underscore that Morgan Keegan knew about, and easily could
have disclosed, the liquidity risk of ARS (especially during
the early 2008 time period), the SEC also points both to a
Morgan Keegan ARS Brochure (published in hard copy) and to the
effective disclosure policy Morgan Keegan instituted after
March 20, 2008.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The ARS Brochure is a short, tri-fold brochure describing
Morgan Keegan's ARS products and their liquidity risk. The ARS
Brochure includes many of the same liquidity risk disclosures
contained on the ARS web page and in the ARS Manual. For
example, the ARS Brochure states that (1) "investing in auction
rate securities involves certain risks that differentiate such
securities from money market investment instruments," (2)
"[t]he ability of an investor to dispose of a share of an
<span CLASS="page_no" data-cite="678 f 3d 1242" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1242" data-primary-citation="678 F.3d 1233">[*1242]</span> 
auction rate security may be largely dependent on the
success of the auction," and (3) "[t]here is no assurance that
any particular auction will be successful, and neither the
issuer nor any broker dealer is obligated to take any action to
ensure that an auction will be successful."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  During 2007 and 2008, Morgan Keegan had hard copies of the ARS
Brochure available at some of its office branches.<a HREF="#fn500" name="fnref_fn500">[fn5]</a> Morgan
Keegan also emailed the ARS Brochure to all of its brokers, but
there is no evidence that Morgan Keegan emailed the brochure to
customers purchasing ARS. Instead, Morgan Keegan provided the
brochure to customers <i>only upon request.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Morgan Keegan did institute a new disclosure policy on March
20, 2008, after the collapse of the ARS market. Under the new
policy, Morgan Keegan required prospective ARS customers to
sign this statement: "I understand that many auction rate
securities are currently, or have been recently, failing at
auction. I understand that it may be a considerable period of
time before liquidity returns to this investment and I view
this with a longer term horizon."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>H. Morgan Keegan's Alleged Oral Mis-representations</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  During the early 2008 auction failures in the ARS market,
Morgan Keegan continued to sell ARS. Between January 2 and
March 19, 2008,<a HREF="#fn600" name="fnref_fn600">[fn6]</a> Morgan Keegan sold approximately $647
million of ARS to about 1,145 customers. This is the time frame
at issue in this SEC enforcement action.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The SEC contends that, in late 2007 continuing through the
collapse of the ARS market in February 2008, Morgan Keegan's
brokers misrepresented ARS liquidity risk in an attempt to
increase <span CLASS="page_no" data-cite="2012 bl 107481 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> sales. The SEC cites the testimony of four customers
who stated that Morgan Keegan brokers misled them regarding the
risk associated with ARS. These four Morgan Keegan customers
testified that Morgan Keegan brokers told them that ARS (1)
were "as good as cash"; (2) were "as good as money"; (3) were
"just like money markets and CDs"; (4) were "cash equivalents
to CDs and money markets"; (5) were "just as good as" an
investment in a CD insured by the FDIC; (6) were "completely
liquid" except for a "possible 35-day hold"; (7) presented
"zero concerns [and] zero risk"; and (8) involved "absolutely
no risk."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The customers averred that the brokers did not disclose the
possibility of an auction failure and the associated liquidity
risk. They testified further that some Morgan Keegan brokers
claimed that ARS investments carried no risk at all. The
SEC contends that these four customers never saw the ARS web page,
the ARS Manual, or the ARS Brochure, and that their brokers
never told them where these documents could be found.
<span CLASS="page_no" data-cite="678 f 3d 1243" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1243" data-primary-citation="678 F.3d 1233">[*1243]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The SEC also submitted written complaints from 14 customers,
including customer letters, civil actions filed in federal
court, arbitration statements of claim filed with the Financial
Industry Regulatory Authority, complaints filed with state
regulators, and complaints filed with the SEC. These written
complaints identified similar misrepresentations of the
liquidity risk of ARS by Morgan Keegan brokers.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                         <b>II. PROCEDURAL HISTORY</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  On July 21, 2009, the SEC sued Morgan Keegan for securities
fraud in violation of <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)&amp;summary=yes#jcite">&sect; 17(a)</a> of the Securities Act
(Counts One and Two); <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">&sect; 10(b)</a> of the Exchange Act and <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>
promulgated thereunder (Count Three); and <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X7FH2G003?jcsearch=15%20U.S.C.%20%2078o(c)(1)&amp;summary=yes#jcite">&sect; 15(c)(1)</a> of the
Exchange Act (Count Four). The complaint alleged that Morgan
Keegan's brokers and marketing materials misrepresented ARS as
cash alternatives and omitted mention that ARS carried
liquidity risk.<a HREF="#fn700" name="fnref_fn700">[fn7]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The SEC's complaint sought this relief: (1) findings that
Morgan Keegan committed the violations alleged in the
complaint, (2) a permanent injunction prohibiting Morgan Keegan
from violating <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">&sect;&sect; 10(b)</a> and <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X7FH2G003?jcsearch=15%20U.S.C.%20%2078o(c)(1)&amp;summary=yes#jcite">15(c)(1)</a> of the
Exchange Act, and <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)&amp;summary=yes#jcite">&sect; 17(a)</a> of the Securities Act, (3) an
order requiring Morgan Keegan "to repurchase all ARS that the
Defendant sold prior to March 20, 2008," (4) disgorgement of
"all ill-gotten gains or unjust enrichment," and (5) civil
monetary penalties in accord with <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1I003?jcsearch=15%20U.S.C.%2077t(d)&amp;summary=yes#jcite">&sect; 20(d)</a> of the Securities
Act and <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE78003?jcsearch=15%20U.S.C.%20%2078u(d)(3)&amp;summary=yes#jcite">&sect; 21(d)(3)</a> of the Exchange Act.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Following discovery, Morgan Keegan moved for summary judgment
on all counts on the ground that the undisputed facts failed to
show a "material" misrepresentation or omission, as required
for liability under the Exchange Act, the Securities Act, and
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>. In a thorough order, the district court granted
Morgan Keegan's motion. <i>SEC v. Morgan Keegan</i>
<i>&amp; Co.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XKOKRGN?jcsearch=806%20f%20supp%202d%201253&amp;summary=yes#jcite">806 F.Supp.2d 1253</a> (N.D.Ga. 2011). The district court
first analyzed Morgan Keegan's distribution of its written
disclosures about liquidity risk and concluded they were
adequately distributed. <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XKOKRGN?jcsearch=806%20F.%20Supp.%202d%201253&amp;summary=yes#jcite">Id. at 1260-62</a>. As to the
materiality issue, the district court noted that oral
misrepresentations are not immaterial simply because proper
written disclosures exist but then concluded that "the oral
statements of four brokers out <span CLASS="page_no" data-cite="2012 bl 107481 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> of hundreds would not lead a
rational jury to believe that Morgan Keegan, as a whole,
misrepresented the risks of ARS investments to its
customers."<a HREF="#fn800" name="fnref_fn800">[fn8]</a> <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XKOKRGN?jcsearch=806%20F.%20Supp.%202d%201253&amp;summary=yes#jcite">Id. at 1265</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The district court observed that the Supreme Court's standard
for materiality &mdash; whether a reasonable investor would
view certain information as significantly altering the "total
mix" of information available &mdash; works well when (1) a
securities dealer makes a misrepresentation to an individual
who brings a private action against the dealer, or (2) when a
dealer makes a mis-representation to the public, in a press
release for example, and the SEC brings an enforcement action
on behalf of the public. <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XKOKRGN?jcsearch=806%20F.%20Supp.%202d%201253&amp;summary=yes#jcite">Id. at 1266</a>. The district
court characterized this case as a "hybrid case where the
SEC claims that Morgan Keegan misled the public through the oral
statements made to four individuals." <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XKOKRGN?jcsearch=806%20F.%20Supp.%202d%201253&amp;summary=yes#jcite">Id</a>.</i> In granting
summary judgment to Morgan Keegan, the district court concluded
that
<span CLASS="page_no" data-cite="678 f 3d 1244" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1244" data-primary-citation="678 F.3d 1233">[*1244]</span> 
the SEC "must do more than show a few isolated instances of
alleged broker misconduct to obtain the relief it seeks."
<i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XKOKRGN?jcsearch=806%20F.%20Supp.%202d%201253&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The SEC appeals.<a HREF="#fn900" name="fnref_fn900">[fn9]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                             <b>III. DISCUSSION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The SEC alleges that Morgan Keegan violated <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">&sect;&sect; 10(b)</a> and
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X7FH2G003?jcsearch=15%20U.S.C.%20%2078o(c)(1)&amp;summary=yes#jcite">15(c)(1)</a> of the Exchange Act, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)&amp;summary=yes#jcite">&sect; 17(a)</a> of the Securities
Act, and SEC <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>. To prove a violation of <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">&sect; 10(b)</a> or
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>,<a HREF="#fn1000" name="fnref_fn1000">[fn10]</a> the SEC must show (1) a material
misrepresentation or materially misleading omission, (2) in
connection with the purchase or sale of a security, (3) made
with scienter. <i>SEC v. Merck Capital, LLC</i>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X16JIJO003?jcsearch=483%20f%203d%20747&amp;summary=yes#jcite">483 F.3d 747</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X16JIJO003?jcsearch=483%20f%203d%20747&amp;summary=yes#jcite">766</a> (11th Cir. 2007). The elements of a <cite>&sect; 15(c)(1)</cite>
claim are the same as a <cite>&sect; 10(b)</cite> claim.<a HREF="#fn1100" name="fnref_fn1100">[fn11]</a> <i>SEC v.</i>
<i>George</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X12O6LK003?jcsearch=426%20f%203d%20786&amp;summary=yes#jcite">426 F.3d 786</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X12O6LK003?jcsearch=426%20f%203d%20786&amp;summary=yes#jcite">792</a> (6th Cir. 2005). To show a
violation of <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)(1)&amp;summary=yes#jcite">&sect; 17(a)(1)</a>, the SEC must prove (1) a material
misrepresentation or materially misleading omission, (2) in the
offer or sale of a security, (3) made with scienter. <i>Merck</i>
<i>Capital</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X16JIJO003?jcsearch=483%20f%203d%20747&amp;summary=yes#jcite">483 F.3d at 766</a>. Finally, to establish a
violation of <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)(2)&amp;summary=yes#jcite">&sect; 17(a)(2)</a> or <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)(3)&amp;summary=yes#jcite">17(a)(3)</a>,<a HREF="#fn1200" name="fnref_fn1200">[fn12]</a> the SEC must
show (1) a material misrepresentation or materially misleading
omission, (2) in the offer or sale of a security, (3) made with
negligence. <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X16JIJO003?jcsearch=483%20F.3d%20747&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  An important distinction exists between the elements of a
private enforcement action and an SEC enforcement action. In a
private enforcement action under <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">&sect; 10(b)</a> or <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>, the
plaintiff also must show "justifiable reliance" on the material
misstatement or omission and that the misstatement caused the
plaintiffs damages. <i>See Bruschi v. Brown</i>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20f%202d%201526&amp;summary=yes#jcite">876 F.2d 1526</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20f%202d%201526&amp;summary=yes#jcite">1529</a> (11th Cir. 1989). "Justifiable reliance," however, is
not an element of an SEC enforcement action because Congress
designated the SEC as the primary enforcer of the securities
laws, and a private plaintiffs "reliance" does not bear on the
determination of whether the securities laws were violated,
only whether that private plaintiff may recover damages.
<i>See SEC v. Rana Research, Inc.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O1HM?jcsearch=8%20f%203d%201358&amp;summary=yes#jcite">8 F.3d 1358</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O1HM?jcsearch=8%20f%203d%201358&amp;summary=yes#jcite">1364</a> (9th
Cir. 1993) ("The SEC need not prove reliance in its action for
injunctive relief on the basis of violations of <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">section 10(b)</a>
and <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>."); <i>SEC v. Blavin</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NRON?jcsearch=760%20f%202d%20706&amp;summary=yes#jcite">760 F.2d 706</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NRON?jcsearch=760%20f%202d%20706&amp;summary=yes#jcite">711</a>
(6th Cir. 1985) ("Unlike private litigants seeking damages, the
Commission is not required to prove that any investor actually
relied on the misrepresentations or that the misrepresentations
caused any investor to lose money."); <i>see also Merck</i>
<i>Capital</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X16JIJO003?jcsearch=483%20f%203d%20747&amp;summary=yes#jcite">483 F.3d at 766</a> (not including "reliance" in the
elements of a <cite>&sect; 10(b)</cite> action in an SEC enforcement action).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In its summary-judgment motion, Morgan Keegan challenged only
the SEC's failure <span CLASS="page_no" data-cite="2012 bl 107481 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> to meet the "materiality" element of each of
its claims. Accordingly, the district court assumed that the
SEC had met the other elements, namely that Morgan Keegan's
brokers made oral misrepresentations or omissions "in
connection with" the purchase or sale of securities, and that
these misrepresentations or omissions were made with scienter
or negligence, as appropriate. <i>Morgan Keegan</i>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XKOKRGN?jcsearch=806%20f%20supp%202d%201253&amp;summary=yes#jcite">806 F.Supp.2d at 1259-60</a>. Because both the district court and the
parties on appeal addressed only "materiality," we do the same.
<span CLASS="page_no" data-cite="678 f 3d 1245" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1245" data-primary-citation="678 F.3d 1233">[*1245]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>A. The Test for Materiality</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The U.S. Supreme Court has developed the materiality test in a
series of <i>private actions</i> in which the plaintiff
investors alleged that the defendant company's <i>public</i>
statements were misleading. <i>See Matrixx Initiatives, Inc.</i>
<i>v. Siracusano</i>, <cite>___ U.S. ___</cite>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20supreme%20court%201309&amp;summary=yes#jcite">131 S.Ct. 1309</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=179%20l%20ed%202d%20398&amp;summary=yes#jcite">179 L.Ed.2d 398</a> (2011); <i>Basic Inc. v. Levinson</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20us%20224&amp;summary=yes#jcite">485 U.S. 224</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. 978</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=99%20l%20ed%202d%20194&amp;summary=yes#jcite">99 L.Ed.2d 194</a> (1988); <i>TSC Industries, Inc. v.</i>
<i>Northway, Inc.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=426%20us%20438&amp;summary=yes#jcite">426 U.S. 438</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=96%20supreme%20court%202126&amp;summary=yes#jcite">96 S.Ct. 2126</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=48%20l%20ed%202d%20757&amp;summary=yes#jcite">48 L.Ed.2d 757</a> (1976). The parties agree that this materiality test also
applies in this SEC enforcement action.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The modern test for determining materiality derives from the
Supreme Court's 1976 decision in <i>TSC Industries v.</i>
<i>Northway, Inc.</i>, which involved a minority shareholder's
allegation that the defendant companies' joint proxy statement
was materially misleading, in violation of <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE6A003?jcsearch=15%20U.S.C.%20%2078n(a)&amp;summary=yes#jcite">&sect; 14(a)</a> of the
Exchange Act. <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=426%20us%20438&amp;summary=yes#jcite">426 U.S. at 441</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=96%20supreme%20court%202126&amp;summary=yes#jcite">96 S.Ct. at 2129</a>. The Supreme
Court noted the "universal[] agree[ment]" that materiality is
an "objective" inquiry involving the significance of an omitted
or misrepresented fact to a reasonable investor. <i>Id.</i>,
at 445, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=96%20supreme%20court%202126&amp;summary=yes#jcite">96 S.Ct. at 2130</a>. In <i>TSC Industries</i>, the
Supreme Court adopted this standard for materiality in a proxy
solicitation: "An omitted fact is material if there is a
substantial likelihood that a reasonable share-holder would
consider it important in deciding how to vote." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=426%20U.S.%20438&amp;summary=yes#jcite">Id.
at 449</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=96%20supreme%20court%202126&amp;summary=yes#jcite">96 S.Ct. at 2132</a>. In other words, a misstatement or
omission is material if there is a "substantial likelihood that
the disclosure of the omitted fact would have been viewed by
the reasonable investor as having significantly altered the
`total mix' of information made available." <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=426%20U.S.%20438&amp;summary=yes#jcite">Id</a>.; see also</i>
<i>SEC v. Ginsburg</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X6CSTH?jcsearch=362%20f%203d%201292&amp;summary=yes#jcite">362 F.3d 1292</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X6CSTH?jcsearch=362%20f%203d%201292&amp;summary=yes#jcite">1302</a> (11th Cir. 2004)
("Materiality is proved by showing a substantial likelihood
that the disclosure of the omitted fact would have been viewed
by the reasonable investor as having significantly altered the
`total mix' of information made available." (quotation marks
omitted)); <i>Merck Capital</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X16JIJO003?jcsearch=483%20f%203d%20747&amp;summary=yes#jcite">483 F.3d at 766</a> (applying
"reasonable man" standard).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In its next major materiality decision, <i>Basic Inc. v.</i>
<i>Levinson</i> in 1988, the Supreme Court expressly applied the
<i>TSC Industries</i> materiality test to a fraud case under
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">&sect; 10(b)</a> of the Exchange Act and <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>.
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20us%20224&amp;summary=yes#jcite">485 U.S. at 231-32</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 983</a> (stating that "to fulfill the
materiality requirement there must be a substantial likelihood
that the disclosure of the omitted fact would have been viewed
by the reasonable investor as having significantly altered the
`total mix' of information made available" (quotation marks
omitted)). The plaintiffs in <i>Basic</i> were former
share-holders who sold their shares after the defendant company
issued public statements denying preliminary merger
negotiations, even though the defendant was in merger
negotiations with a larger company. <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20U.S.%20224&amp;summary=yes#jcite">Id. at 227-28</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 981</a>. The defendant <span CLASS="page_no" data-cite="2012 bl 107481 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[**11]</span> company in <i>Basic</i> proposed
a bright-line rule for determining the materiality of merger
negotiations &mdash; "merger discussions do not become material
until `agreement-in-principle' as to the price and structure of
the transaction has been reached between the would-be merger
partners." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20U.S.%20224&amp;summary=yes#jcite">Id. at 233</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 984</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Basic</i>, the Supreme Court acknowledged that
considering merger negotiations "material" only after an
agreement in principle was reached would be an easy materiality
test to apply. <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20U.S.%20224&amp;summary=yes#jcite">Id. at 236</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 986</a>. However,
"[a]ny approach that designates a single fact or occurrence as
always determinative of <i>an inherently fact-specific finding</i>
<i>such as materiality</i>, must necessarily be overinclusive or
underinclusive." <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20U.S.%20224&amp;summary=yes#jcite">Id</a>.</i> (emphasis added). Noting that the
materiality test "requires delicate assessments of the
inferences a `reasonable shareholder' would draw from
<span CLASS="page_no" data-cite="678 f 3d 1246" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1246" data-primary-citation="678 F.3d 1233">[*1246]</span> 
a given set of facts and the significance of those
inferences to him," the Supreme Court rejected the
"agreement-in-principle" test as underinclusive. <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20U.S.%20224&amp;summary=yes#jcite">Id</a>.; see</i>
<i>also Ginsburg</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X6CSTH?jcsearch=362%20f%203d%201292&amp;summary=yes#jcite">362 F.3d at 1302</a> (noting that materiality
"requires delicate assessments of the inferences a reasonable
[investor] would draw from a given set of facts" and that
"these assessments are peculiarly ones for the trier of fact"
(quoting <i>TSC Indus.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=426%20us%20438&amp;summary=yes#jcite">426 U.S. at 450</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=96%20supreme%20court%202126&amp;summary=yes#jcite">96 S.Ct. at 2133</a>)). The Supreme Court found "no valid justification for
artificially excluding <i>from the definition of</i>
<i>materiality</i> information concerning merger discussions,
which would otherwise be considered significant to the trading
decision of a reasonable investor, merely because
agreement-in-principle as to price and structure has not yet
been reached by the parties or their representatives."
<i>Basic</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20us%20224&amp;summary=yes#jcite">485 U.S. at 236</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 986</a> (emphasis
added).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Rather, Basic concluded that "materiality depends on the
significance the reasonable investor would place on the
withheld or misrepresented information." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20U.S.%20224&amp;summary=yes#jcite">Id. at 240</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 988</a>. The role of the materiality inquiry is "to
filter out essentially <i>useless information that a</i>
<i>reasonable investor would not consider significant</i>, even
as part of a larger `mix' of factors to consider in making his
investment decision." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20U.S.%20224&amp;summary=yes#jcite">Id. at 234</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 985</a>
(emphasis added). Thus, "[w]hether merger discussions in any
particular case are material . . . depends on the facts."
<i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20U.S.%20224&amp;summary=yes#jcite">Id. at 239</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 987</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The Supreme Court's recent application of the materiality test
in <i>Matrixx Initiatives, Inc. v. Siracusano</i> is also
instructive as to what number of adverse events it takes to
make certain information "significant" to the reasonable
investor. <cite>___ U.S. ___</cite>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20supreme%20court%201309&amp;summary=yes#jcite">131 S.Ct. 1309</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=179%20l%20ed%202d%20398&amp;summary=yes#jcite">179 L.Ed.2d 398</a> (2011).
There the plaintiff investors sued Matrixx, a pharmaceutical
company, for failing to disclose reports of adverse events
caused by Matrixx's Zicam cold-remedy product, in violation of
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">&sect; 10(b)</a> of the Exchange Act and <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>. The plaintiffs
alleged that Matrixx knew of reports from several doctors that
their patients lost their senses of smell after using
Zicam.<a HREF="#fn1300" name="fnref_fn1300">[fn13]</a> Yet, Matrixx issued positive earnings expectations
and failed to disclose that it already was defending
product-liability lawsuits involving Zicam.<a HREF="#fn1400" name="fnref_fn1400">[fn14]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Matrixx's defense was that the plaintiff investors failed to
allege a "statistically significant correlation <span CLASS="page_no" data-cite="2012 bl 107481 p 12" data-cite-type="Bloomberg" data-cite-pageno="12" data-primary-citation="">[**12]</span> between the use
of Zicam and [loss of smell] so as to make failure to publicly
disclose complaints and [the doctors' reports] a material
omission." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">Id. at 1317</a>. Rejecting this argument, the
<span CLASS="page_no" data-cite="678 f 3d 1247" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1247" data-primary-citation="678 F.3d 1233">[*1247]</span> 
Supreme Court noted that &mdash; like the defendant company
in <i>Basic</i> &mdash; Matrixx was proposing a "bright-line
rule that reports of adverse events associated with a
pharmaceutical company's products cannot be material absent a
sufficient number of such reports to establish a statistically
significant risk that the product is in fact causing the
events." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">Id. at 1318-19</a> (footnote omitted). But this
proposed rule would "artificially exclude information that
would otherwise be considered significant to the trading
decision of a reasonable investor." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">Id. at 1319</a>
(alteration and quotation marks omitted). The Supreme Court
reasoned that statistically significant data are not always
available and that medical researchers and the FDA routinely
rely on other evidence to establish an inference of causation.
"Given that medical professionals and regulators act on the
basis of evidence of causation that is not statistically
significant, it stands to reason that in certain cases
reasonable investors would as well." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">Id.
at 1321</a>.<a HREF="#fn1500" name="fnref_fn1500">[fn15]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>B. The "Total Mix" of Information in an SEC Enforcement</b>
<b>Action</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We now apply this materiality test to the facts of this
SEC enforcement action. To do so, however, we must answer the
threshold question of whether, in an SEC enforcement action, a
misstatement or omission by an individual broker to an
individual investor may be included in the analysis of the
"total mix" of information available to the hypothetical
reasonable investor. For several reasons, we conclude that the
brokers' alleged misstatements are included in the materiality
inquiry in an SEC enforcement action.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Morgan Keegan's principal argument on appeal is that an
SEC enforcement action is designed to protect the public as a
whole, and therefore the SEC must demonstrate that Morgan
Keegan misled the public as a whole and not just a small subset
of customers. Morgan Keegan argues that the "materiality" of a
mis-representation in an SEC enforcement action is evaluated in
the context of only disclosures to the public as a whole and
without any consideration of a broker's communications to a
particular investor.<a HREF="#fn1600" name="fnref_fn1600">[fn16]</a>
<span CLASS="page_no" data-cite="678 f 3d 1248" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1248" data-primary-citation="678 F.3d 1233">[*1248]</span> 
This argument fails because the Supreme Court's materiality
standard analyzes the "total mix" of information available to a
hypothetical reasonable investor, not just to the public at
large. <i>See Matrixx</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">131 S.Ct. at 1318</a> (stating the
test for materiality is whether there is "a substantial
likelihood that the disclosure of the omitted fact would have
been viewed by the <i>reasonable investor</i> as having
significantly altered the `total mix' of information made
available" (emphasis added) (quotations marks omitted));
<i>see also Basic</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20us%20224&amp;summary=yes#jcite">485 U.S. at 236</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 986</a>
(stating the materiality analysis "requires delicate
assessments of the inferences a `<i>reasonable</i>
<i>shareholder</i>' would draw from a given set of facts and the
significance of those inferences to <i>him</i>" (emphasis
added)); <i>Merck Capital</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X16JIJO003?jcsearch=483%20f%203d%20747&amp;summary=yes#jcite">483 F.3d at 768-71</a> (applying
"reasonable <span CLASS="page_no" data-cite="2012 bl 107481 p 13" data-cite-type="Bloomberg" data-cite-pageno="13" data-primary-citation="">[**13]</span> man" standard). In other words, the materiality
test requires the court to consider <i>all</i> the
information available to the hypothetical reasonable investor,
which necessarily includes private communications. <i>See</i>
<i>Aaron v. SEC.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6TH?jcsearch=446%20us%20680&amp;summary=yes#jcite">446 U.S. 680</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6TH?jcsearch=446%20us%20680&amp;summary=yes#jcite">682-83</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6TH?jcsearch=100%20supreme%20court%201945&amp;summary=yes#jcite">100 S.Ct. 1945</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6TH?jcsearch=100%20supreme%20court%201945&amp;summary=yes#jcite">1948-49</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6TH?jcsearch=64%20l%20ed%202d%20611&amp;summary=yes#jcite">64 L.Ed.2d 611</a> (1980) (considering, in SEC enforcement
action against managerial employee of broker-dealer, misleading
statements by two individual brokers to prospective investors).
By failing to consider the brokers' alleged oral
misrepresentations, Morgan Keegan's analysis deprives the
publicly available written disclosures of their complete
context and deprives its brokers' oral misrepresentations of
any role in SEC enforcement actions.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The problem for Morgan Keegan is the SEC enjoys the authority
to seek relief for <i>any</i> violation of the securities
laws, no matter how small or inconsequential.<a HREF="#fn1700" name="fnref_fn1700">[fn17]</a> And it is
well-settled that a violation of <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(b)&amp;summary=yes#jcite">&sect; 10(b)</a> of the Exchange
Act requires only a (1) material misrepresentation or
materially misleading omission, (2) in connection with the
purchase or sale of securities, (3) made with scienter.
<i>Merck Capital</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X16JIJO003?jcsearch=483%20f%203d%20747&amp;summary=yes#jcite">483 F.3d at 766</a>. The SEC thus may seek
a civil penalty against any defendant who has made a single
misstatement or omission, if material and made with scienter
and in connection with the purchase or sale of
securities.<a HREF="#fn1800" name="fnref_fn1800">[fn18]</a> Morgan Keegan cannot show that its oral
misstatements were immaterial merely by showing that those
statements were not made publicly.
<span CLASS="page_no" data-cite="678 f 3d 1249" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1249" data-primary-citation="678 F.3d 1233">[*1249]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, a rule excluding all individual broker-investor
communications from the materiality inquiry is underinclusive,
just like the "agreement-in-principle" rule the Supreme Court
rejected in <i>Basic</i> and the "statistical significance"
rule it rejected in <i>Matrixx. See Basic</i>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20us%20224&amp;summary=yes#jcite">485 U.S. at 236</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 986</a>; <i>Matrixx</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">131 S.Ct. at 1319</a>.
That is, the hypothetical reasonable investor looking for a
short-term, liquid investment is likely to consider his
broker's statements about the relative merit (and lack of risk)
of certain investments in deciding among different investment
options.<a HREF="#fn1900" name="fnref_fn1900">[fn19]</a> And the fact-finder could easily conclude that a
reasonable investor would find liquidity risk an important
factor in determining whether to invest in ARS, especially
given Morgan Keegan's advertising ARS as a highly liquid
alternative to money market funds.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Further, there is no statutory or precedential support for
Morgan Keegan's argument that some threshold number of
investors must be misled before finding its brokers'
misrepresentations "material" in an SEC enforcement action. The
SEC is not required to prove an institution-wide effort by
brokers to mislead customers in order to bring or to prevail in
an SEC enforcement action. The extent of the brokers'
misrepresentations may ultimately affect the size of the
remedy, such as fines or disgorgement imposed, but there is no
minimum number of misrepresentations required for a materiality
finding in an SEC enforcement action. Simply put, a numerical
threshold for materiality runs counter to the securities acts'
broad grant of authority to the SEC to bring an action for any
violation of the securities laws.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In this case, the SEC presented <span CLASS="page_no" data-cite="2012 bl 107481 p 14" data-cite-type="Bloomberg" data-cite-pageno="14" data-primary-citation="">[**14]</span> evidence that four Morgan
Keegan brokers misrepresented the liquidity risk of ARS to
customers.<a HREF="#fn2000" name="fnref_fn2000">[fn20]</a> Under principles of <i>respondeat</i>
<i>superior</i>, Morgan Keegan is liable for the acts of these
brokers so long as they acted within the scope of their
authority. <i>See Paul F. Newton &amp; Co. v. Tex. Commerce</i>
<i>Bank</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NOTL?jcsearch=630%20f%202d%201111&amp;summary=yes#jcite">630 F.2d 1111</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NOTL?jcsearch=630%20f%202d%201111&amp;summary=yes#jcite">1118</a> (5th Cir. 1980) (concluding that
"common law agency principles, including the doctrine of
respondeat superior, remain viable in actions" under the
Exchange Act).<a HREF="#fn2100" name="fnref_fn2100">[fn21]</a> Morgan Keegan concedes that these four
brokers were acting within the scope of their authority when
they made the alleged misrepresentations. Thus, the SEC, at a
minimum, may establish a securities violation with respect to
each of those four investors irrespective of "an institutional
effort to mislead" customers and irrespective of whether any
additional brokers attempted to mislead Morgan Keegan's other
customers. In this SEC enforcement action, we discern no reason
to exclude Morgan Keegan's brokers' misrepresentations
<span CLASS="page_no" data-cite="678 f 3d 1250" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1250" data-primary-citation="678 F.3d 1233">[*1250]</span> 
from the materiality analysis of the "total mix" of
information available to the reasonable investor.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<b>C. The Materiality of Oral Misrepresentations Conflicting</b>
<b>With Morgan Keegan's Written Disclosures Is an Issue for the</b>
<b>Trier of Fact</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Having decided that these alleged oral misrepresentations by
the four Morgan Keegan brokers must be considered for purposes
of materiality, we next determine whether Morgan Keegan's
written disclosures nonetheless rendered its brokers' oral
misrepresentations immaterial as a matter of law. The way
information is disclosed can be as important as its content.
Thus, in evaluating the effect of Morgan Keegan's written
disclosures, we must consider not only the content of the
written disclosures but also the way in which the disclosures
were made. After record review, we conclude that, even if a
brokerage company's written disclosures might render its
individual brokers' oral misstatements immaterial in some
cases, Morgan Keegan's manner of distribution of its written
disclosures in this particular case was insufficient to warrant
summary judgment for Morgan Keegan.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In this regard, the main securities cases the parties cite from
our circuit addressing the interplay of written disclosures and
oral misrepresentations are <i>Bruschi v. Broum</i>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20f%202d%201526&amp;summary=yes#jcite">876 F.2d 1526</a> (11th Cir. 1989), and <i>First Union Discount Brokerage</i>
<i>Servs., Inc. v. Milos</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O4CR?jcsearch=997%20f%202d%20835&amp;summary=yes#jcite">997 F.2d 835</a> (11th Cir. 1993).
Because these two cases involve justifiable reliance rather
than materiality, they are not on point. Yet these cases show
that the effect of oral misrepresentations conflicting with
written disclosures &mdash; whether measured by a private
plaintiffs reliance or by the significance to a hypothetical
reasonable investor &mdash; depends heavily on the facts of
each case.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Bruschi</i>, the defendant-broker gave the written
disclosures directly to the plaintiff-investor, but we
concluded they did not warrant judgment as a matter of law for
the defendant in the plaintiffs private action alleging oral
misrepresentations. The <i>Bruschi</i> plaintiff, an
unsophisticated investor, hired <span CLASS="page_no" data-cite="2012 bl 107481 p 15" data-cite-type="Bloomberg" data-cite-pageno="15" data-primary-citation="">[**15]</span> the defendant Brown as her
broker and investment advisor. <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20F.2d%201526&amp;summary=yes#jcite">Id. at 1527</a>. Employed
at Dean Witter Reynolds, Inc., defendant Brown recommended "the
Elmco investment," which he described in positive terms, and
stated it would provide the plaintiff with "significant tax
deductions." <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20F.2d%201526&amp;summary=yes#jcite">Id</a>.</i> Brown did not disclose that the Elmco
investment was a complex and risky venture involving
unregistered securities and was neither endorsed nor offered by
Dean Witter, or that Elmco was paving Brown a commission for
any securities he sold. Brown visited the plaintiffs home to
close the transaction and gave her 160 pages of documents
describing the merits and risks of the Elmco investment.
<i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20F.2d%201526&amp;summary=yes#jcite">Id. at 1527-28</a>. After Brown assured that her signature
"was a mere formality," the plaintiff signed the documents
without reading them. <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20F.2d%201526&amp;summary=yes#jcite">Id. at 1528</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Defendant Brown argued that the extensive disclosure documents
conflicted with the alleged oral misrepresentations and that,
as a matter of law, "an investor is not justified in relying on
oral misrepresentations that conflict with contemporaneous
written representations." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20F.2d%201526&amp;summary=yes#jcite">Id. at 1529</a>. This Court
noted that it had never held that, "regardless of the
circumstances, an investor is always precluded from recovering
under <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a> if the misrepresentations upon which the
investor relied were oral and conflict in some way with
contemporaneous written representations available to the
investor." <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20F.2d%201526&amp;summary=yes#jcite">Id</a>.</i><a HREF="#fn2200" name="fnref_fn2200">[fn22]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In <i>Bruschi</i> this Court then listed several factors for
determining whether an investor's
<span CLASS="page_no" data-cite="678 f 3d 1251" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1251" data-primary-citation="678 F.3d 1233">[*1251]</span> 
reliance is justified.<a HREF="#fn2300" name="fnref_fn2300">[fn23]</a> This Court concluded that,
"[w]hen all factors are considered, it cannot be held as a
matter of law that [plaintiff] Bruschi's reliance on the
alleged oral misrepresentations was not justified."
<i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20F.2d%201526&amp;summary=yes#jcite">Id. at 1530</a>. Even in <i>Bruschi</i> where the
plaintiff bore the additional burden to show justifiable
reliance, this Court did not allow the written disclosures to
trump oral misrepresentations as a matter of law.<a HREF="#fn2400" name="fnref_fn2400">[fn24]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Subsequently, in <i>First Union v. Milos</i>, this Court
distinguished <i>Bruschi</i> in holding that sophisticated
investors could not have justifiably relied on a broker's oral
representations that "predated and conflicted with the clear
language" of two contracts directly given to and signed by the
investors. 997 F.2d at 846. The <i>First Union</i> Court
stated that "[i]n <i>Bruschi</i>, we explained that
circumstances may warrant departure from the usual presumption
that reliance on an oral representation that a written
representation contradicts is not justified." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O4CR?jcsearch=997%20F.2d%20835&amp;summary=yes#jcite">Id.
at 846</a> n. 22. This Court compared the factual circumstances in
<i>Bruschi</i> and <i>First Union</i> and concluded that
the facts did not warrant departure in <i>First Union</i>:
Factually, <i>Bruschi</i> involved (1) "an offering
memorandum"; (2) an investor who was "unsophisticated and
inexperienced in financial matters" and told not to read the
disclosure documents; (3) a security purchase "initiated" by
the defendant-broker; and (4) "some statements in the
disclosure documents [that] confirmed some of the alleged oral
misrepresentations." <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O4CR?jcsearch=997%20F.2d%20835&amp;summary=yes#jcite">Id</a>.</i> (quotation marks omitted). By
comparison, in <i>First Union<span CLASS="page_no" data-cite="2012 bl 107481 p 16" data-cite-type="Bloomberg" data-cite-pageno="16" data-primary-citation="">[**16]</span> </i>: (1) the disclosures were
in "two written contracts" given directly to a "sophisticated
investor"; (2) the investors "had full control over their
investments"; (3) "the written agreements violently
contradicted the oral representations";
<span CLASS="page_no" data-cite="678 f 3d 1252" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1252" data-primary-citation="678 F.3d 1233">[*1252]</span> 
and (4) First Union did not tell the investors not to read
the written agreements. <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O4CR?jcsearch=997%20F.2d%20835&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  While <i>Bruschi</i> and <i>First Union</i> involve
"justifiable reliance," they nonetheless show that, in
securities cases, whether written disclosures should trump oral
misrepresentations is highly fact-specific and therefore is
not amenable to bright-line rules. <i>Cf. Matrixx</i>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">131 S.Ct. at 1318-19</a>; <i>Basic</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20us%20224&amp;summary=yes#jcite">485 U.S. at 236</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 986</a>; <i>TSC Indus.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=426%20us%20438&amp;summary=yes#jcite">426 U.S. at 450</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=96%20supreme%20court%202126&amp;summary=yes#jcite">96 S.Ct. at 2133</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Here, after considering the entire record, we conclude that
Morgan Keegan's written disclosures do not warrant summary
judgment for Morgan Keegan on the "materiality" issue. The oral
misrepresentations at issue here were made directly to
customer-investors who aver they never received or knew about
the written disclosures at the time of their purchases.
Importantly too, the oral misstatements must be considered in
the factual context of a weak, or non-existent, distribution of
the written disclosures.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For example, although Morgan Keegan produced adequate written
disclosures in the ARS Manual and the ARS Brochure and gave the
ARS Manual directly to customers in 2006, there is no evidence
that, during late 2007 and early 2008, Morgan Keegan directly
gave customers these written disclosures before or after
customers purchased ARS. At most, the record shows that the ARS
Brochure was available at some of Morgan Keegan's branch
offices, but the ARS Brochure was given to customers only upon
a customer's request.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The only written documents that were directly given to ARS
purchasers were the trade confirmations. But the trade
confirmations say absolutely nothing about liquidity risk.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The trade confirmations do refer customers to the website for
"information regarding the auction procedures," but the trade
confirmations list only the Morgan Keegan home page (despite
the cease-and-desist order's explicit instruction<a HREF="#fn2500" name="fnref_fn2500">[fn25]</a> that
the trade confirmations notify customers that a written
description of Morgan Keegan's auction practices "is available
on <i>a specified webpage</i> of [Morgan Keegan's] website").
While the evidence contains a copy of an archived ARS web page
on Morgan Keegan's website, there is no evidence that brokers
directed customers interested in ARS to the ARS web page.<a HREF="#fn2600" name="fnref_fn2600">[fn26]</a>
<span CLASS="page_no" data-cite="678 f 3d 1253" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1253" data-primary-citation="678 F.3d 1233">[*1253]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We recognize that the back of the trade confirmations state
that securities "involve investment risks, including the loss
of principal." But given Morgan Keegan's knowledge of the
increasing rate of auction failures in late 2007 and early
2008, this general cautionary language is insufficient to
render its brokers' oral misrepresentations during that period
immaterial as a matter of Jaw. <i>See Merck Capital</i>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X16JIJO003?jcsearch=483%20f%203d%20747&amp;summary=yes#jcite">483 F.3d at 768</a> (holding that a defendant's performance projections
were materially misleading despite general cautionary language
because the defendant failed to disclose past performance
information "that would be useful to a reasonable investor <span CLASS="page_no" data-cite="2012 bl 107481 p 17" data-cite-type="Bloomberg" data-cite-pageno="17" data-primary-citation="">[**17]</span> in
assessing those [optimistic performance projections]").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, the trade confirmations were provided only after the
ARS purchase and after the alleged oral misrepresentations. And
because nothing in the trade confirmations discloses the
liquidity risk of ARS, customers would have no reason to
investigate whether to use the ten-day provision to rescind the
transaction. Accordingly, the ten-day-rescission remedy is
insufficient to support a finding, as a matter of law, that the
brokers' oral misstatements were immaterial.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Despite failing to provide its written disclosures directly to
customers, Morgan Keegan argues that the written disclosures
were available to any "<i>reasonably diligent investor.</i>"
But due diligence is a distinct and subjective element of a
private action under <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a>, unrelated to the objective
materiality test. <i>Thompson v. Smith Barney, Harris Upham</i>
<i>&amp; Co.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O0R5?jcsearch=709%20f%202d%201413&amp;summary=yes#jcite">709 F.2d 1413</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O0R5?jcsearch=709%20f%202d%201413&amp;summary=yes#jcite">1418</a> (11th Cir. 1983) (" `[D]ue
diligence' [is] a separate element in 10b-5 cases, apart from
questions of materiality, reliance, or defendants' duties.").
And, because due diligence focuses on whether "the carelessness
of a plaintiff should preclude his recovery," it is properly
considered only in a private action brought by an investor, not
an SEC enforcement action. <i>See </i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O0R5?jcsearch=709%20F.2d%201413&amp;summary=yes#jcite">id. at 1418</a> n. 7.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In sum, the materiality inquiry in this SEC enforcement action
must account for the oral misrepresentations of Morgan Keegan's
brokers. Because Morgan Keegan's written disclosures were not
given directly to customers but were distributed only in the
weak or non-effective manner outlined above, we conclude that
the brokers' misleading statements and failure to disclose the
known liquidity risk of ARS could have "been viewed by the
reasonable investor as having significantly altered the `total
mix' of information made available." <i>See Basic</i>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=485%20us%20224&amp;summary=yes#jcite">485 U.S. at 231-32</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N742?jcsearch=108%20supreme%20court%20978&amp;summary=yes#jcite">108 S.Ct. at 983</a> (quotation marks omitted).
Indeed, as noted above, the materiality test requires "delicate
assessments of the inferences a `reasonable shareholder' would
draw from a given set of facts and the significance of those
inferences to him, and these assessments are peculiarly ones
for the trier of fact." <i>TSC Indus.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=426%20us%20438&amp;summary=yes#jcite">426 U.S. at 450</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2N6LN?jcsearch=96%20supreme%20court%202126&amp;summary=yes#jcite">96 S.Ct. at 2133</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
                             <b>IV. CONCLUSION</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  For these reasons, we conclude that the district court erred in
granting summary judgment for Morgan Keegan based on the
"materiality" element of the securities violations charged in
this SEC enforcement action. Our holding is narrow and limited
to materiality. We do not address whether the SEC has met any
other element of its claims or whether the SEC will ultimately
prevail in this litigation.<a HREF="#fn2700" name="fnref_fn2700">[fn27]</a> Accordingly,
<span CLASS="page_no" data-cite="678 f 3d 1254" data-cite-type="PrimaryFederalReporter" data-cite-pageno="1254" data-primary-citation="678 F.3d 1233">[*1254]</span> 
we vacate the district court's June 28, 2011 order granting
summary judgment to Morgan Keegan and remand for further
proceedings consistent with this opinion.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>VACATED AND REMANDED.</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> The auction failures did not affect customers' receipt of
interest and principal payments as scheduled. Further, the ARS
market did not completely dry up because some investors were
willing to sacrifice liquidity for the higher interest payments
&mdash; the maximum rate &mdash; resulting from the auction
failures.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> The complaint alleges that, as of July 15, 2009, Morgan
Keegan customers held about $272 million of illiquid ARS,
approximately $50 million of which was underwritten by Morgan
Keegan.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> This statement is in the same font size as the rest of
the information but is in bold typeface and all capital
letters.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> The ARS web page in the record is an archived version of
a web page, but the ARS Manual in the record appears to be a
hard copy of the Manual. We note that, in the top right side of
the ARS web page, there is the term "Auction Rate Securities
Practices and Procedures," which is also the full title of the
ARS Manual. However, Morgan Keegan's brief has not cited
evidence to us showing whether this language is a link or, if
so, whether the link retrieves the ARS Manual. In any event, it
appears that a customer would have to get to the ARS web page
(or the five-page archived version of the web page that is in
the record) and then proceed to the ARS Manual. The SEC does
not dispute that the ARS Manual was somewhere on Morgan
Keegan's website.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> Disputing the availability of hard copies of the ARS
Brochure, the SEC points out that Morgan Keegan (1) did not
post the ARS Brochure on its public website, (2) did not
require the ARS Brochure to be distributed to each branch
office before March 20, 2008, (3) did not track which branches
requested or received hard copies of the ARS Brochure, (4) had
no means of identifying or determining whether hard copies were
distributed to brokers at each branch office, and (5) had no
standard practice or procedure regarding where and how hard
copies of the ARS Brochure were displayed, maintained, or
disseminated within each branch office.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> The SEC chose to end the time period for this action on
March 20, 2008, apparently because that date was when Morgan
Keegan instituted its new policy of requiring ARS customers to
sign a statement that they understood the liquidity risk of ARS
and viewed the ARS investment "with a longer term
horizon."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> The complaint also alleged that Morgan Keegan's brokers
were insufficiently trained on the liquidity risk of ARS and
that Morgan Keegan continued to push ARS despite knowledge of
significant and increasing risk associated with ARS. These
claims are not on appeal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> Although the SEC submitted written complaints by 14 other
customers, the district court declined to consider this
evidence on the ground that the statements were inadmissible
hearsay. <i>Morgan Keegan</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XKOKRGN?jcsearch=806%20f%20supp%202d%201253&amp;summary=yes#jcite">806 F.Supp.2d at 1265</a>
n. 12.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn900" name="fn900">[fn9]</a></span> "We review the entry of summary judgment <i>de</i>
<i>novo.</i> . . ." <i>SEC v. Warren</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X18SI9U003?jcsearch=534%20f%203d%201368&amp;summary=yes#jcite">534 F.3d 1368</a>,
1369(11th Cir. 2008).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1000" name="fn1000">[fn10]</a></span> <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(B)&amp;summary=yes#jcite">Section 10(b)</a> of the Exchange Act is codified at
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE5S003?jcsearch=15%20U.S.C.%20%2078j(B)&amp;summary=yes#jcite">15 U.S.C. &sect; 78j</a>(b). <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a> is codified at
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">17 C.F.R. &sect; 240.10b-5</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1100" name="fn1100">[fn11]</a></span> <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X7FH2G003?jcsearch=15%20U.S.C.%20%2078o(c)&amp;summary=yes#jcite">Section 15(c)</a> of the Exchange Act is codified at
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X7FH2G003?jcsearch=15%20U.S.C.%20%2078o(c)&amp;summary=yes#jcite">15 U.S.C. &sect; 78o</a>(c).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1200" name="fn1200">[fn12]</a></span> <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)&amp;summary=yes#jcite">Section 17(a)</a> of the Securities Act is codified at
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1A003?jcsearch=15%20U.S.C.%20%2077q(a)&amp;summary=yes#jcite">15 U.S.C. &sect; 77q</a>(a).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1300" name="fn1300">[fn13]</a></span> Although Matrixx was aware of these doctors' reports,
Matrixx relied on its own clinical trials and issued a press
release stating that (1) Zicam products were manufactured and
marketed in compliance with FDA guidelines, (2) "Matrixx
believes statements alleging that intranasal Zicam products
caused anosmia (loss of smell) are completely unfounded and
misleading," and (3) in two double-blind, placebo-controlled,
randomized clinical trials, there were no reports of anosmia
and "no statistically significant difference between the
adverse event rates for the treated and placebo subsets."
<i>Matrixx</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">131 S.Ct. at 1316</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1400" name="fn1400">[fn14]</a></span> In October 2003, Matrixx reported that Zicam was "poised
for growth in the upcoming cough and cold season" and predicted
a 50% revenue increase and earnings per share of between 25 to
30 cents. <i>Matrixx</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">131 S.Ct. at 1315</a>. In its 10-Q
filed with the SEC in November 2003, Matrixx warned that
product-liability claims, "whether or not proven to be valid,"
could have a "material adverse effect" on its product branding
and goodwill. <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">Id</a>.</i> Matrixx did not disclose that two
plaintiffs had sued, alleging Zicam caused their loss of smell.
Then, in January 2004, Matrixx raised its revenue growth
prediction to 80% and its earnings-per-share estimate to 33 to
38 cents. <i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1500" name="fn1500">[fn15]</a></span> Applying the <i>Basic</i> "total mix" standard, the
Supreme Court in <i>Matrixx</i> concluded that, at the motion
to dismiss stage, materiality was established under these facts
alleged in the complaint: (1) Matrixx received information from
medical experts revealing a plausible connection between Zicam
and the loss of smell, (2) consumers would likely have viewed
the risk of losing the sense of smell as outweighing the
benefit of using Zicam to alleviate cold symptoms, and (3)
Zicam accounted for 70% of Matrixx's sales. The Supreme Court
concluded that these facts suggested "a significant risk to the
commercial viability of Matrixx's leading product" and that a
reasonable investor would view information about this risk to
the company's leading product as "significantly alter[ing] the
total mix of information made available." <i>Matrixx</i>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1F576K003?jcsearch=131%20S.%20Ct.%201309&amp;summary=yes#jcite">131 S.Ct. at 1323</a> (quotation marks omitted).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1600" name="fn1600">[fn16]</a></span> Citing <i>Dupuy v. Dupuy</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X3U86G?jcsearch=551%20f%202d%201005&amp;summary=yes#jcite">551 F.2d 1005</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X3U86G?jcsearch=551%20f%202d%201005&amp;summary=yes#jcite">1015</a> (5th
Cir. 1977), Morgan Keegan argues that "materiality in
SEC enforcement actions is appropriately evaluated in the context
of disclosures made `to the public, not to any particular
investor.'" Morgan Keegan cites <i>Dupuy</i> wholly out of
context. First, the issue in <i>Dupuy</i> was whether the
private plaintiff acted with due diligence, not whether the
defendant's misrepresentations and omissions were material.
Second, <i>Dupuy</i> does not purport to limit
SEC enforcement actions in any way. Rather, the Court was
explaining that the subjective knowledge or diligence of any
particular investor is not relevant to an SEC enforcement
action, which focuses on whether a defendant violated the
securities laws, not whether any particular investor was
harmed.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  If anything, <i>Dupuy</i> bolsters our conclusion that the
brokers' statements must be included in the materiality inquiry
by stating that the "standard of conduct for defendants
logically should be the same whether the SEC or a private
litigant enforces the duty" imposed by the securities laws.
<i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X3U86G?jcsearch=551%20F.2d%201005&amp;summary=yes#jcite">Id</a>.</i> Because the materiality test determines whether a
defendant's conduct violates the securities laws, the
materiality test "logically should be the same whether the
SEC or a private litigant enforces the duty." <i>See <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X3U86G?jcsearch=551%20F.2d%201005&amp;summary=yes#jcite">id</a>.</i> The
materiality test will be the same only if the "total mix" of
information is the same in an SEC enforcement action as it is
in a private enforcement action.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1700" name="fn1700">[fn17]</a></span> Both the Securities Act and the Exchange Act permit the
SEC to bring a civil action either to enjoin or to impose a
civil penalty for any violation of the federal securities laws.
<i>See</i> <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1I003?jcsearch=15%20U.S.C.%20%2077t(b)&amp;summary=yes#jcite">15 U.S.C. &sect; 77t</a>(b) ("Whenever it shall appear
to the Commission that any person is engaged or about to engage
in any acts or practices which constitute or will constitute a
violation of the [Securities Act], or of any rule or regulation
prescribed under authority thereof, the Commission may, in its
discretion, bring an action in any district court of the United
States . . . to enjoin such acts or practices. . . .");
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE78003?jcsearch=15%20U.S.C.%20%2078u(d)(1)&amp;summary=yes#jcite">15 U.S.C. &sect; 78u</a>(d)(1) ("Whenever it shall appear to the
Commission that any person is engaged or is about to engage in
acts or practices constituting a violation of any provision of
[the Exchange Act], the rules or regulations thereunder, [or]
the rules of a national securities exchange or registered
securities association of which such person is a member or a
person associated with a member . . . it may in its discretion
bring an action in the proper district court of the United
States . . . to enjoin such acts or practices. . . .");
<i>see also</i> <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE1I003?jcsearch=15%20U.S.C.%20%2077t(d)&amp;summary=yes#jcite">15 U.S.C. &sect;&sect; 77t</a>(d), <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XEHE78003?jcsearch=15%20U.S.C.%20%2078u(d)(3)&amp;summary=yes#jcite">78u</a>(d)(3)
(authorizing the SEC to seek a monetary civil penalty against
any person who "has violated any provision" of the Securities
Act or the Exchange Act).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1800" name="fn1800">[fn18]</a></span> Other limitations &mdash; such as money or time &mdash;
may counsel against the SEC's prosecuting such actions. But the
statutes grant the SEC this broad authority.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn1900" name="fn1900">[fn19]</a></span> Because this is an SEC enforcement action, we need not
determine whether the individual investor's <i>reliance</i>
on his broker's statements is reasonable.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2000" name="fn2000">[fn20]</a></span> The SEC argues that the district court abused its
discretion by refusing to consider the SEC's evidence of other
alleged misrepresentations, including written complaints by 14
other customers that their Morgan Keegan brokers had
misrepresented the liquidity risk of ARS. Because we conclude
that the SEC met its burden to show "materiality" with respect
to the misstatements to the four investors, we need not address
whether the district court erred in excluding this evidence as
hearsay during the summary judgment stage. We recognize that
the SEC argues that the district court may consider hearsay
when ruling on summary judgment if the statement could be
reduced to admissible evidence at trial. The SEC will have an
opportunity to do just that as to these 14 customers on remand
during the trial.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2100" name="fn2100">[fn21]</a></span> This Court adopted as binding precedent all Fifth
Circuit decisions prior to October 1, 1981. <i>Bonner v. City</i>
<i>of Prichard</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NPGJ?jcsearch=661%20f%202d%201206&amp;summary=yes#jcite">661 F.2d 1206</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NPGJ?jcsearch=661%20f%202d%201206&amp;summary=yes#jcite">1209</a> (11th Cir. 1981) (en
banc).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2200" name="fn2200">[fn22]</a></span> In <i>Bruschi</i>, although the oral
"misrepresentations conflicted with statements in the
disclosure documents that the economic and tax risks were
substantial," the Court also noted that "[t]he disclosure
documents . . . were consistent with Brown's alleged oral
misrepresentations that (1) there were no material
relationships between himself and Elmco and (2) that he had not
and would not be receiving any compensation from Elmco."
<i>Bruschi</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20f%202d%201526&amp;summary=yes#jcite">876 F.2d at 1530</a>. "Thus, even if Bruschi had
read the disclosure documents, she would have received
conflicting signals as to the reliability of the alleged oral
misrepresentations rather than the obvious indication of
unreliability argued by Brown."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2300" name="fn2300">[fn23]</a></span> The <i>Bruschi</i> court listed these factors: "(1)
the sophistication and expertise of the plaintiff in financial
and security matters; (2) the existence of long standing
business or personal relationships between the plaintiff and
the defendant; (3) the plaintiff's access to relevant
information; (4) the existence of a fiduciary relationship owed
by the defendant to the plaintiff, (5) concealment of fraud by
the defendant; (6) whether the plaintiff initiated the stock
transaction or sought to expedite the transaction; and (8) the
generality or specificity of the misrepresentations."
<i>Bruschi v. Brown</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20f%202d%201526&amp;summary=yes#jcite">876 F.2d 1526</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2NTI5?jcsearch=876%20f%202d%201526&amp;summary=yes#jcite">1529</a> (11th
Cir. 1989).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2400" name="fn2400">[fn24]</a></span> Morgan Keegan also relies on <i>Acme Propane, Inc. v.</i>
<i>Tenexco, Inc.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O3HE?jcsearch=844%20f%202d%201317&amp;summary=yes#jcite">844 F.2d 1317</a> (7th Cir. 1988), but that
private action involved written disclosures that were given
<i>directly</i> to the plaintiff investors. <i>Acme</i>
<i>Propane</i> does include a curious footnote stating that,
although the precedent it cited was interpreting the reliance
element of a securities fraud claim, "`reliance' in securities
law is just a code word for causation, which in turn usually
means a material misstatement." <i></i><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X2O3HE?jcsearch=844%20F.2d%201317&amp;summary=yes#jcite">Id. at 1322</a> n. *.
However, this is an SEC enforcement action, which requires no
showing of justifiable reliance.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, the Supreme Court's cases establish an objective,
reasonable-investor standard for determining "materiality."
Reliance, in contrast, focuses on the individual
investor-plaintiff. <i>Stoneridge Inv. Partners, LLC v.</i>
<i>Scientific-Atlanta, Inc.</i>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X18CV6U003?jcsearch=552%20us%20148&amp;summary=yes#jcite">552 U.S. 148</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X18CV6U003?jcsearch=552%20us%20148&amp;summary=yes#jcite">159</a>,
<a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X18CV6U003?jcsearch=128%20supreme%20court%20761&amp;summary=yes#jcite">128 S.Ct. 761</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X18CV6U003?jcsearch=128%20supreme%20court%20761&amp;summary=yes#jcite">769</a>, <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X18CV6U003?jcsearch=169%20l%20ed%202d%20627&amp;summary=yes#jcite">169 L.Ed.2d 627</a> (2008) (stating the reliance element
of a private action under <a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/XMIE6Q003?jcsearch=17%20C.F.R.%20%20240.10b-5&amp;summary=yes#jcite">Rule 10b-5</a> "ensures that . . . the
requisite causal connection between a defendant's
misrepresentation and a plaintiff's injury exists as a
predicate for liability" (quotation marks omitted)). To the
extent the <i>Acme Propane</i> footnote says that justifiable
reliance and materiality are the same inquiry, we find <i>Acme</i>
<i>Propane</i> unpersuasive and rely instead on the Supreme
Court's materiality cases outlined above.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2500" name="fn2500">[fn25]</a></span> At oral argument, Morgan Keegan argued that the
SEC should be estopped from arguing that Morgan Keegan had not met
its disclosure requirements because the cease-and-desist order
explicitly states that a broker-dealer could meet its
disclosure obligations <i>under the cease-and-desist</i>
<i>order</i> by including a note in the confirmation that the
broker-dealer's "material auction practices and procedures" is
available on a specified web page on the broker-dealer's
website. We are not persuaded. The cease-and-desist order deals
with the distinct violation of failing to disclose auction
practices and procedures, not with misrepresenting or failing
to disclose the liquidity risk of ARS. In other words, the fact
that a broker-dealer has adequately disclosed its ARS auction
procedures does not absolve the broker-dealer of liability for
its brokers' materially misleading statements about the
liquidity risk of ARS.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2600" name="fn2600">[fn26]</a></span> At this summary judgment stage, we need not resolve the
dispute over how many steps a customer would need to reach the
ARS web page because Morgan Keegan has not presented evidence
that anyone ever visited the ARS web page or that any of its
brokers ever directed a customer to its ARS web page. At oral
argument, Morgan Keegan's attorney mentioned that a customer
could enter "auction" in the search box on its homepage and
thereby reach the ARS web page. We cannot find that in the
record either. In any event, Morgan Keegan's manner of
distributing its written disclosures of ARS liquidity risk in
2008 does not warrant summary judgment for Morgan Keegan.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn2700" name="fn2700">[fn27]</a></span> In ruling on materiality, we have no occasion to address
the remedies being sought by the SEC. Upon remand, both parties
should be given the opportunity to develop and litigate the
remedies being sought. If the SEC prevails and shows a
securities violation or violations, the fact-finder then can
consider the appropriate size and scope of the remedies.
</p></div>
<!--BBLS DD 1705907257347-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HKNVU003/history">Direct History (2)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1HKNVU003/analysis">Case Analysis (10)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1HKNVU003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
10
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Judgment Vacated, Case Remanded (Per Curiam)</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Industries</div><div class='facetItemLabel'>Investment Companies/Mutual Funds</div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/document/X1Q6M0S2G3O2">11-13992 (11th Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Contracts</div><div class='facetItemLabel'>Securities Law</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/e2ce47aedc09393b1f207adc43ffc06c/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "e2ce47aedc09393b1f207adc43ffc06c";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY4d2a5c&previousPageId=&previousActivityInstanceId=ENTITY5014e4&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:47:38-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1HKNVU003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY5014e4&previousPageId=&previousActivityInstanceId=ENTITY8217e4&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T00:47:34-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1HKNVU003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1HKNVU003";
$('#page_loader').show().spin();
JUDGE_IDS=["3028840","3028854"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
